Benjamin Edwards’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $86.6M | Buy |
331,067
+3,745
| +1% | +$960K | 0.78% | 17 |
|
|
2026
Q2 | $82.4M | Sell |
327,322
-11,582
| -3% | -$2.49M | 0.75% | 19 |
|
|
2026
Q1 | $73.7M | Sell |
338,904
-1,639
| -0.5% | -$364K | 0.73% | 22 |
|
|
2025
Q4 | $77.8M | Sell |
340,543
-45,929
| -12% | -$10.5M | 0.86% | 14 |
|
|
2025
Q3 | $89.5M | Buy |
386,472
+12,094
| +3% | +$2.46M | 1.01% | 12 |
|
|
2025
Q2 | $69.5M | Buy |
374,378
+8,191
| +2% | +$1.52M | 0.88% | 18 |
|
|
2025
Q1 | $76.7M | Buy |
366,187
+14,089
| +4% | +$2.74M | 1.07% | 10 |
|
|
2024
Q4 | $62.6M | Buy |
352,098
+16,132
| +5% | +$2.97M | 0.9% | 16 |
|
|
2024
Q3 | $66.4M | Buy |
335,966
+298,322
| +792% | +$55.7M | 0.97% | 12 |
|
|
2024
Q2 | $6.46M | Sell |
37,644
-5,212
| -12% | -$863K | 1.24% | 10 |
|
|
2024
Q1 | $7.8M | Buy |
42,856
+2,851
| +7% | +$491K | 1.55% | 6 |
|
|
2023
Q4 | $6.2M | Buy |
40,005
+4,376
| +12% | +$638K | 1.35% | 6 |
|
|
2023
Q3 | $5.31M | Buy |
35,629
+145
| +0.4% | +$21.3K | 1.26% | 6 |
|
|
2023
Q2 | $4.78M | Buy |
35,484
+4,311
| +14% | +$632K | 1.11% | 16 |
|
|
2023
Q1 | $4.97M | Buy |
31,173
+3,638
| +13% | +$556K | 1.21% | 14 |
|
|
2022
Q4 | $4.45M | Buy |
27,535
+694
| +3% | +$106K | 1.17% | 12 |
|
|
2022
Q3 | $3.6M | Buy |
26,841
+471
| +2% | +$67.6K | 1.08% | 12 |
|
|
2022
Q2 | $4.04M | Sell |
26,370
-144
| -0.5% | -$22K | 1.19% | 8 |
|
|
2022
Q1 | $4.3M | Buy |
26,514
+10,961
| +70% | +$1.59M | 1.25% | 9 |
|
|
2021
Q4 | $2.11M | Buy |
15,553
+14,157
| +1,014% | +$1.67M | 0.68% | 36 |
|
|
2021
Q3 | $151K | Buy |
1,396
+693
| +99% | +$79.2K | 0.09% | 198 |
|
|
2021
Q2 | $79K | Buy |
703
+18
| +3% | +$2.03K | 0.05% | 240 |
|
|
2021
Q1 | $74K | Buy |
685
+62
| +10% | +$6.63K | 0.06% | 230 |
|
|
2020
Q4 | $67K | Sell |
623
-49
| -7% | -$4.71K | 0.05% | 223 |
|
|
2020
Q3 | $59K | Buy |
672
+6
| +0.9% | +$565 | 0.05% | 204 |
|
|
2020
Q2 | $65K | Sell |
666
-66
| -9% | -$5.81K | 0.05% | 185 |
|
|
2020
Q1 | $56K | Buy |
732
+188
| +35% | +$16K | 0.06% | 164 |
|
|
2019
Q4 | $48K | Buy |
544
+144
| +36% | +$12K | 0.1% | 132 |
|
|
2019
Q3 | $30K | Hold |
400
| – | – | 0.07% | 143 |
|
|
2019
Q2 | $29K | Hold |
400
| – | – | 0.07% | 143 |
|
|
2019
Q1 | $32K | Buy |
+400
| New | +$32.7K | 0.15% | 136 |
|
Other funds holding ABBV
Benjamin Edwards's ABBV Position: Q3 2026 in Review
Benjamin Edwards increased its AbbVie (ABBV) stake by 1.1% in Q3 2026, buying an estimated $960K and bringing the position to 331,067 shares worth $86.6M. The position accounts for 0.78% of the portfolio, ranked #17.
Benjamin Edwards first reported a position in ABBV in Q1 2019 and has held it in 31 quarters since. The position peaked at $89.5M in Q3 2025. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Benjamin Edwards held 331,067 shares of AbbVie worth $86.6M as of Q3 2026.
- Benjamin Edwards bought 3,745 AbbVie shares in Q3 2026, an estimated $960K.
- AbbVie made up 0.78% of Benjamin Edwards's portfolio in Q3 2026, its #17 holding.
- Benjamin Edwards first reported a position in AbbVie in Q1 2019 and has held it in 31 quarters since.
- Benjamin Edwards's AbbVie position peaked at $89.5M in Q3 2025.
- 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.